Twins studies as a model for studies on the interaction between smoking and genetic factors in the development of chronic bronchitis.

Smoking is the main risk factor for COPD (chronic obstructive pulmonary disease) but genetic factors are of importance, since only a subset of smokers develops the disease. Sex differences have been suggested both in disease prevalence and response to environmental exposures. Furthermore, it has been shown that acquisition of 'addiction' to smoking is partly genetically mediated. Disease cases and smoking habits were identified in 44919 twins aged >40 years from the Swedish Twin Registry. Disease was defined as self-reported chronic bronchitis or emphysema, or recurrent cough with phlegm. The results showed that chronic bronchitis seems to be more prevalent among females, and that the heritability estimate for chronic bronchitis was a moderate 40% and only 14% of the genetic influences were shared by smoking. In addition, 392 twins have been invited to a clinical investigation to evaluate: (i) to what extent genetic factors contribute to individual differences (variation) in FEV(1) (forced expiratory volume in 1 s), vital capacity and DL(CO) (diffusion capacity), taking sex into consideration, and (ii) whether smoking behaviour and respiratory symptoms influence these estimates.

[1]  N. Molfino.  Current thinking on genetics of chronic obstructive pulmonary disease , 2007, Current opinion in pulmonary medicine.

[2]  K. Rabe,et al.  From COPD to chronic systemic inflammatory syndrome? , 2007, The Lancet.

[3]  G. Mcclearn,et al.  Genetic and environmental influences on pulmonary function in aging Swedish twins. , 1994, Journal of gerontology.

[4]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[5]  M. McGue.  When assessing twin concordance, use the probandwise not the pairwise rate. , 1992, Schizophrenia bulletin.

[6]  P. Nilsson,et al.  Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study , 2008, Thorax.

[7]  R. Carrell,et al.  SMOKING, LUNG FUNCTION, AND α1-ANTITRYPSIN DEFICIENCY , 1985, The Lancet.

[8]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[9]  R. Kronmal,et al.  Inflammatory markers and longitudinal lung function decline in the elderly. , 2008, American journal of epidemiology.

[10]  M Svartengren,et al.  Genes, environments, and sex: factors of importance in atopic diseases in 7—9–year‐old Swedish twins , 1997, Allergy.

[11]  B. Hedblad,et al.  Lung Function and Cardiovascular Risk: Relationship With Inflammation-Sensitive Plasma Proteins , 2002, Circulation.

[12]  D. Mannino,et al.  Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. , 2003, The American journal of medicine.

[13]  M. Zureik,et al.  Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. , 2006, Respiratory medicine.

[14]  N. Anthonisen,et al.  C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease , 2006, Thorax.

[15]  P. Lichtenstein,et al.  The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies , 2002, Journal of internal medicine.

[16]  B. Nordestgaard,et al.  Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[17]  N. Martin,et al.  The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. , 2004, Twin research : the official journal of the International Society for Twin Studies.

[18]  Juni Palmgren,et al.  The Swedish Twin Registry in the Third Millennium: An Update , 2006, Twin Research and Human Genetics.

[19]  K. Chapman.  Chronic obstructive pulmonary disease: are women more susceptible than men? , 2004, Clinics in chest medicine.

[20]  M. Bots,et al.  rediction of Mortality Risk in the Elderly , 2006 .

[21]  A Senthilselvan,et al.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.

[22]  A. Eggen,et al.  Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001. , 2007, Respiratory medicine.

[23]  L. F. Black,et al.  alpha1-Antitrypsin deficiency in nonsmokers. , 1978, The American review of respiratory disease.

[24]  G. Mcclearn,et al.  Longitudinal and genetic effects in the relationship between pulmonary function and cognitive performance. , 1998, The journals of gerontology. Series B, Psychological sciences and social sciences.

[25]  Michael J. Allison,et al.  COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. , 2007, Chest.

[26]  K Larsson,et al.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2003, Respiratory medicine.

[27]  M. Feinleib,et al.  Genetic and environmental influences on pulmonary function in adult twins. , 2015, The American review of respiratory disease.

[28]  Yasutaka Nakano,et al.  Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[29]  E. Wouters,et al.  Raised CRP levels mark metabolic and functional impairment in advanced COPD , 2005, Thorax.

[30]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[31]  B. Beghé,et al.  Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. , 2002, American journal of respiratory and critical care medicine.

[32]  T. McKeever,et al.  Systemic inflammation and decline in lung function in a general population: a prospective study , 2007, Thorax.

[33]  G. Vogler,et al.  Methodology for genetic studies of twins and families , 1993 .

[34]  N. Buist,et al.  Neonatal screening for alpha1-antitrypsin deficiency. , 1978, The Journal of pediatrics.

[35]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[36]  S. Bojesen,et al.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[37]  K. Philipson,et al.  Tracheobronchial clearance in smoking-discordant twins. , 1972, Archives of environmental health.

[38]  K. Philipson,et al.  Tracheobronchial clearance in twins. , 1972, Archives of environmental health.

[39]  N. Pedersen,et al.  Interaction between smoking and genetic factors in the development of chronic bronchitis. , 2008, American journal of respiratory and critical care medicine.

[40]  S. Antoniu,et al.  Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.

[41]  N. Wareham,et al.  Siblings of Patients with Severe Chronic Obstructive Pulmonary Disease Have a Significant Risk of Airflow Obstruction , 2002 .

[42]  D. Sin,et al.  Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. , 2003, Circulation.

[43]  F. Speizer,et al.  Assessment of genetic and nongenetic influences on pulmonary function. A twin study. , 2015, The American review of respiratory disease.